Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 4:2022:2900378.
doi: 10.1155/2022/2900378. eCollection 2022.

Ultrasound Comparative Analysis of Coronary Arteries before and after Immune Blocking Therapy with Gamma Globulin in Children with Kawasaki Disease

Yi Yu  1 , Jinhua Hu  1 , Qun Xia  1 , Juxia Huang  1 , Yangmei Cheng  1 , Fangling Wu  1 , Yujing Liu  1 , Jun Wang  1 , Qiong Zhang  2
Affiliations

Ultrasound Comparative Analysis of Coronary Arteries before and after Immune Blocking Therapy with Gamma Globulin in Children with Kawasaki Disease

Yi Yu et al. Evid Based Complement Alternat Med. .

Retraction in

Abstract

Objective: To investigate the ultrasound characteristics and clinical efficacy of coronary arteries before and after immune blocking therapy with gamma globulin in children with Kawasaki disease.

Methods: A total of 64 children with Kawasaki disease who were treated in our hospital from January 2018 to October 2021 were selected. All the children were given immune blocking therapy with gamma globulin on the basis of conventional treatment. The disappearance time of related symptoms and signs (fever, mucosal congestion, cervical lymphadenopathy, and swelling of the hands and feet) in children were counted. The white blood cell count (WBC), platelet count (PLT), C-reactive protein (CRP), and procalcitonin (PCT) levels of the children before and after treatment were compared, and the characteristics of coronary echocardiography before and after treatment were observed for analysis and discussion, to carefully observe whether the coronary artery involvement of the children was improved.

Results: The inner diameter of the left and right coronary arteries significantly decreased (P < 0.05), and the levels of leukocytes, platelets, CRP, erythrocyte sedimentation rate, vascular endothelial growth factor (VEGF), and endostatin were significantly decreased compared with those before treatment, with a statistical difference (P < 0.05).

Conclusion: The effect of gamma globulin in the treatment of Kawasaki disease is remarkable, which can improve the blood indexes, VEGF, and endostatin levels in children, significantly reduce coronary dilatation, and reduce the incidence of coronary artery disease. Echocardiography is of high value in the examination of children with Kawasaki disease, which can accurately detect the size, location, and inner diameter of coronary artery lesions, and can effectively evaluate the treatment effect on children.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
Changes in the inner diameter of the left and right coronary arteries before and after treatment. (a) The ultrasound results of the left coronary artery and (b) the right coronary artery before treatment. (c) The ultrasound results of the left coronary artery and (d) the right coronary artery three months after gamma globulin immunoblocking therapy.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Butters C., Curtis N., Burgner D. P. Kawasaki disease fact check: myths, misconceptions and mysteries. Journal of Paediatrics and Child Health . 2020;56(9):1343–1345. doi: 10.1111/jpc.15101. - DOI - PubMed
    1. Frenkel L. D., Gomez F., Bellanti J. A. COVID-19 in children: pathogenesis and current status. Allergy and Asthma Proceedings . 2021;42(1):8–15. doi: 10.2500/aap.2021.42.200104. - DOI - PubMed
    1. Iio K., Uda K., Hataya H., et al. Kawasaki disease or Kawasaki-like disease: influence of SARS-CoV-2 infections in Japan. Acta Paediatrica . 2021;110(2):600–601. doi: 10.1111/apa.15535. - DOI - PMC - PubMed
    1. Uehara R., Belay E. D. Epidemiology of Kawasaki disease in asia, Europe, and the United States. Journal of Epidemiology . 2012;22(2):79–85. doi: 10.2188/jea.je20110131. - DOI - PMC - PubMed
    1. Lo M. S. A framework for understanding Kawasaki disease pathogenesis. Clinical Immunology . 2020;214 doi: 10.1016/j.clim.2020.108385.108385 - DOI - PubMed

Publication types